131 related articles for article (PubMed ID: 38521374)
1. Biodegradable zwitterionic polymer-cloaked defective metal-organic frameworks for ferroptosis-inducing cancer therapy.
Zhang M; Yao X; Xu J; Song J; Mai S; Zhu W; Zhang Y; Zhu L; Yang W
Int J Pharm; 2024 Apr; 655():124032. PubMed ID: 38521374
[TBL] [Abstract][Full Text] [Related]
2. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
3. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
4. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
5. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy.
Hu X; Li R; Wu W; Fang K; Zhu Z; Wang Y; Zhou L; Chen M; Dong C; Shi S
J Control Release; 2022 Aug; 348():660-671. PubMed ID: 35716884
[TBL] [Abstract][Full Text] [Related]
6. Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination.
Rao Z; Xia Y; Jia Q; Zhu Y; Wang L; Liu G; Liu X; Yang P; Ning P; Zhang R; Zhang X; Qiao C; Wang Z
J Nanobiotechnology; 2023 Aug; 21(1):265. PubMed ID: 37563614
[TBL] [Abstract][Full Text] [Related]
7. Iron ion and sulfasalazine-loaded polydopamine nanoparticles for Fenton reaction and glutathione peroxidase 4 inactivation for enhanced cancer ferrotherapy.
Zhu X; Chen Q; Xie L; Chen W; Jiang Y; Song E; Song Y
Acta Biomater; 2022 Jun; 145():210-221. PubMed ID: 35470077
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironments self-activated nanoscale metal-organic frameworks for ferroptosis based cancer chemodynamic/photothermal/chemo therapy.
Liang Y; Zhang L; Peng C; Zhang S; Chen S; Qian X; Luo W; Dan Q; Ren Y; Li Y; Zhao B
Acta Pharm Sin B; 2021 Oct; 11(10):3231-3243. PubMed ID: 34729312
[TBL] [Abstract][Full Text] [Related]
9. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Targeted Cascade Nanoreactor Based on Metal-Organic Frameworks for Synergistic Ferroptosis-Starvation Anticancer Therapy.
Wan X; Song L; Pan W; Zhong H; Li N; Tang B
ACS Nano; 2020 Sep; 14(9):11017-11028. PubMed ID: 32786253
[TBL] [Abstract][Full Text] [Related]
11. Zwitterionic polymer coated sorafenib-loaded Fe
Lin J; Zhang J; Wang K; Guo S; Yang W
J Mater Chem B; 2022 Aug; 10(30):5784-5795. PubMed ID: 35861050
[TBL] [Abstract][Full Text] [Related]
12. Redox Responsive Metal Organic Framework Nanoparticles Induces Ferroptosis for Cancer Therapy.
He H; Du L; Guo H; An Y; Lu L; Chen Y; Wang Y; Zhong H; Shen J; Wu J; Shuai X
Small; 2020 Aug; 16(33):e2001251. PubMed ID: 32677157
[TBL] [Abstract][Full Text] [Related]
13. Parallel Lipid Peroxide Accumulation Strategy Based on Bimetal-Organic Frameworks for Enhanced Ferrotherapy.
Xin H; Wang F; Luo R; Lei J
Chemistry; 2021 Mar; 27(13):4307-4311. PubMed ID: 33377225
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Amplification of Ferroptosis with Liposomal Oxidation Catalyst and Gpx4 Inhibitor for Enhanced Cancer Therapy.
Yuan Y; Tian C; Wang Q; Qiu X; Wang Y; Jiang H; Hao J; He Y
Adv Healthc Mater; 2023 Nov; 12(28):e2301292. PubMed ID: 37458333
[TBL] [Abstract][Full Text] [Related]
15. Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator.
He YJ; Liu XY; Xing L; Wan X; Chang X; Jiang HL
Biomaterials; 2020 May; 241():119911. PubMed ID: 32143060
[TBL] [Abstract][Full Text] [Related]
16. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
[TBL] [Abstract][Full Text] [Related]
17. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy.
Yang S; Wong KH; Hua P; He C; Yu H; Shao D; Shi Z; Chen M
Acta Biomater; 2022 Mar; 140():492-505. PubMed ID: 34879292
[TBL] [Abstract][Full Text] [Related]
18. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
19. Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy.
Liu X; Zhu X; Qi X; Meng X; Xu K
Int J Nanomedicine; 2021; 16():1037-1050. PubMed ID: 33603367
[TBL] [Abstract][Full Text] [Related]
20. Three-Step Depletion Strategy of Glutathione: Tunable Metal-Organic-Framework-Engineered Nanozymes for Driving Oxidative/Nitrative Stress to Maximize Ferroptosis Therapy.
Li W; Liu S; Ding H; Zhao R; Zang P; Li S; Fang L; Li R; Zhang M; Yang P
Nano Lett; 2024 Feb; 24(6):2071-2080. PubMed ID: 38305186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]